Francesco Schittulli
Lega Italiana per la Lotta ai Tumori · 110 works · 2,591 citations · h-index 26
Top works
- Multicenter Validation of a Gene Expression–Based Prognostic Signature in Lymph Node–Negative Primary Breast Cancer
- The 76-gene signature defines high-risk patients that benefit from adjuvant tamoxifen therapy
- Impact of follow-up testing on survival and health-related quality of life in breast cancer patients. A multicenter randomized controlled trial. The GIVIO Investigators
- Biomarkers predictive for clinical efficacy of taxol-based chemotherapy in advanced breast cancer
- Cytoskeleton and paclitaxel sensitivity in breast cancer: The role of β‐tubulins
- Comparison of formalin, ethanol, and Histochoice fixation on the PCR amplification from paraffin-embedded breast cancer tissue.
- Nonrandom Distribution of Aberrant Promoter Methylation of Cancer-Related Genes in Sporadic Breast Tumors
- Prognostic Relevance of Mitotic Activity in Patients with Node-Negative Breast Cancer
- Adjuvant hormonetherapy for slow proliferating node-negative breast cancer patients. Results of the phase III trial of NCl-Bari
- Association of Breast Cancer and Polymorphisms of Interleukin-10 and Tumor Necrosis Factor-α Genes
- A prothrombotic state in breast cancer patients treated with adjuvant chemotherapy
- Heterogeneity of intratumour proliferative activity in primary breast cancer: Biological and clinical aspects
- Prognostic relevance of histological grade and its components in node-negative breast cancer patients
- DNA-methylation of the homeodomain transcription factor PITX2 reliably predicts risk of distant disease recurrence in tamoxifen-treated, node-negative breast cancer patients – Technical and clinical validation in a multi-centre setting in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC) PathoBiology group
- HER-2 Expression and Cell Proliferation: Prognostic Markers in Patients With Node-Negative Breast Cancer
- Ovarian fibroma: our experience of 34 cases.
- Aging impacts transcriptomes but not genomes of hormone-dependent breast cancers
- MMP-2, MMP-9, VEGF and CA 15.3 in breast cancer.
- Chemotherapy-induced ovarian toxicity in patients affected by endocrine-responsive early breast cancer
- Genetic alterations in hereditary breast cancer